News Articles for "Humira"
Drugmaker AbbVie rises following analyst upgrade
Shares of drugmaker AbbVie Inc. rose to its highest point Monday after a Morgan Stanley analyst upgraded the stock, expecting greater sales of the Chicago...read more
Rigel slumps on rheumatoid arthritis drug results
Shares of Rigel Therapeutics Inc. lost more than a third of their value Friday on mixed results from a late-stage clinical trial of a rheumatoid arthritis...read more
Abbvie sets first annual guidance after spinoff
Abbvie Inc., the pharmaceutical spinoff of Abbott Laboratories, issued its first annual guidance Wednesday, straddling Wall Street estimates. On Jan. 1 Ab...read more
Eli Lilly & Co. said Thursday that it stopped one late-stage trial of its experimental drug tabalumab as a treatment for rheumatoid arthritis. Lilly said ...read more